N

Novo Nordisk
NOVO B

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
DKK1.90T
EV
DKK1.98T
Shares Outstanding
4.44B
Beta
0.21

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
DKK690.76
P/E 2025E
16.83x
P/Revenue 2025E
5.82x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Novo Nordisk A/S

gainify

N

Novo Nordisk A/S

NOVO B

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates i...

Sector

Healthcare

Industry

Biotechnology

CEO

Jorgensen, Lars

Employees

77,406

IPO Date

2001-01-06

Headquarters

Novo Alle 1, Bagsvaerd, Capital Region of Denmark, 2880, Denmark

gainify
mailcontactcontact
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.